MedTrace Logo

Exome Sequencing for Atypical Femoral Fractures

NCT02731040 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38

Last updated 2018-12-31

No results posted yet for this study

Summary

The purpose of this study is to determine whether women who have atypical subtrochanteric and diaphyseal femoral fractures after treatment with bisphosphonates for osteoporosis, have a genetic predisposition to these unusual fractures.

Conditions

  • Atypical Femoral Fractures
  • Osteoporosis
  • Bisphosphonate Therapy

Interventions

DRUG

Bisphosphonate

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Steven Mumm, PhD · Washington University School of Medicine

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2018-03-29
Completion
2018-03-29

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02731040 on ClinicalTrials.gov